[Efficacy of finasteride in the treatment of hematuria associated with benign prostatic hypertrophy].
OBJECTIVE
To evaluate the efficacy of finasteride in the treatment of prostatic origin haematuria.


METHODS
This is a prospective observational study in 29 patients with hematuria from a demonstrated prostatic-origin which were treated with finasteride 5 mg/day. 58.6% had undergone previous prostatic surgery. Both previous-to-treatment hematuria and response to treatment were evaluated under the Puchner & Miller's criteria.


RESULTS
Response rate was 86.2% without additional haematuria episodes. The remaining patients had mild haematuria episodes during follow-up. No patient needed surgery.


CONCLUSIONS
Finasteride is effective in the treatment of prostatic-origin haematuria.
Palou Redorta
Juan
J
Servicio de Urología, Fundació Puigvert, Universidad Autónoma de Barcelona, Barcelona, España.
Gausa Gascon
Luis
L
Salvador Bayarre
José
J
Millán Rodríguez
Félix
F
Segarra Tomás
José
J
Villavicencio Mavrich
Humberto
H
D058891:5-alpha Reductase Inhibitors; D000368:Aged; D015897:Comorbidity; D003920:Diabetes Mellitus / Q000453:epidemiology; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D018120:Finasteride / Q000627:therapeutic use*; D006417:Hematuria / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D006973:Hypertension / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000453:epidemiology; D011183:Postoperative Complications; D011446:Prospective Studies; D011468:Prostatectomy; D011470:Prostatic Hyperplasia / Q000150:complications / Q000188:drug therapy* / Q000601:surgery; D016032:Randomized Controlled Trials as Topic; D012720:Severity of Illness Index; D020728:Transurethral Resection of Prostate; D016896:Treatment Outcome; D014652:Vascular Diseases / Q000453:epidemiology
D058891:5-alpha Reductase Inhibitors; D004791:Enzyme Inhibitors; D018120:Finasteride